COVID-19–Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barré Syndrome

References

1. 1.↵
   2. Zhu N,
   3. Zhang D,
   4. Wang W, et al

   ; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–33 doi:10.1056/NEJMoa2001017 pmid:31978945

   CrossRefPubMed
2. 2.↵
   2. Holshue ML,
   3. DeBolt C,
   4. Lindquist S, et al

   ; Washington State 2019-nCoV Case Investigation Team. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020;382:929–36 doi:10.1056/NEJMoa2001191 pmid:32004427

   CrossRefPubMed
3. 3.↵
   Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19): cases in U.S. 2020. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html#2019coronavirus-summary. Accessed May 13, 2020
4. 4.↵
   2. Mao L,
   3. Jin H,
   4. Wang M, et al

   . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020 Apr 10. [Epub ahead of print] doi:10.1001/jamaneurol.2020.1127 pmid:32275288

   CrossRefPubMed
5. 5.↵
   2. Poyiadji N,
   3. Shahin G,
   4. Noujaim D, et al

   . COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020 Mar 31. [Epub ahead of print] doi:10.1148/radiol.2020201187 pmid:32228363

   CrossRefPubMed
6. 6.↵
   2. Zhang Y,
   3. Xiao M,
   4. Zhang S, et al

   . Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020;382:e38 doi:10.1056/NEJMc2007575 pmid:32268022

   CrossRefPubMed
7. 7.↵
   2. Zhao H,
   3. Shen D,
   4. Zhou H, et al

   . Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 2020;19:383–84 doi:10.1016/S1474-4422(20)30109-5 pmid:32246917

   CrossRefPubMed
8. 8.↵
   2. Toscano G,
   3. Palmerini F,
   4. Ravaglia S, et al

   . Guillain-Barre Syndrome associated with SARS-CoV-2. N Engl J Med 2020;19:383–84 doi:10.1016/S1474-4422(20)30109-5 pmid:32246917

   CrossRefPubMed
9. 9.↵
   2. Wakerley BR,
   3. Yuki N

   . Isolated facial diplegia in Guillain-Barre syndrome: bifacial weakness with paresthesias. Muscle Nerve 2015;52:927–32 doi:10.1002/mus.24887 pmid:26315943

   CrossRefPubMed
10. 10.↵
    2. Kim JK,
    3. Oh SY,
    4. Sohn EH, et al

    . When is facial diplegia regarded as a variant of Guillain-Barre syndrome? J Peripher Nerv Syst 2015;20:32–36 doi:10.1111/jns.12115 pmid:25975218

    CrossRefPubMed
11. 11.↵
    2. Hygino da Cruz LC Jr.,
    3. Nascimento OJ,
    4. Lopes F, et al

    . Neuroimaging findings of Zika virus-associated neurologic complications in adults. AJNR Am J Neuroradiol 2018;39:1967–74 doi:10.3174/ajnr.A5649 pmid:29773562

    Abstract/FREE Full Text
12. 12.↵
    2. Wu S,
    3. Zeng Y,
    4. Lerner A, et al

    . Nervous system injury and neuroimaging of Zika virus infection. Front Neurol 2018;9:227 doi:10.3389/fneur.2018.00227 pmid:29740383

    CrossRefPubMed
13. 13.↵
    2. Zuccoli G,
    3. Panigrahy A,
    4. Bailey A, et al

    . Redefining the Guillain-Barre spectrum in children: neuroimaging findings of cranial nerve involvement. AJNR Am J Neuroradiol 2011;32:639–42 doi:10.3174/ajnr.A2358 pmid:21292802

    Abstract/FREE Full Text
14. 14.↵
    2. Fulbright RK,
    3. Erdum E,
    4. Sze G, et al

    . Cranial nerve enhancement in the Guillain-Barre syndrome. AJNR Am J Neuroradiol 1995;16:923–25 pmid:7611075

    Abstract/FREE Full Text
15. 15.↵
    2. Al Othman B,
    3. Raabe J,
    4. Kini A, et al

    . Update: the Miller Fisher variants of Guillain-Barre syndrome. Curr Opin Ophthalmol 2019;30:462–66 doi:10.1097/ICU.0000000000000611 pmid:31567467

    CrossRefPubMed
16. 16.↵
    2. Byun WM,
    3. Park WK,
    4. Park BH, et al

    . Guillain-Barre syndrome: MR imaging findings of the spine in eight patients. Radiology 1998;208:137–41 doi:10.1148/radiology.208.1.9646804 pmid:9646804

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Dodson SC,
    3. Koontz NA

    . Spinal manifestations of systemic disease. Radiol Clin North Am 2019;57:281–306 doi:10.1016/j.rcl.2018.10.005 pmid:30709471

    CrossRefPubMed
18. 18.↵
    2. Hao Y,
    3. Wang W,
    4. Jacobs BC, et al

    . Antecedent infections in Guillain-Barre syndrome: a single-center, prospective study. Ann Clin Transl Neurol 2019;6:2510–17 doi:10.1002/acn3.50946 pmid:31714025

    CrossRefPubMed
19. 19.↵
    2. Ziganshin RH,
    3. Ivanova OM,
    4. Lomakin YA, et al

    . The pathogenesis of the demyelinating form of Guillain-Barre sndrome (GBS): proteo-peptidomic and immunological profiling of physiological fluids. Mol Cell Proteomics 2016;15:2366–78 doi:10.1074/mcp.M115.056036 pmid:27143409

    Abstract/FREE Full Text
20. 20.↵
    2. De Fine Olivarius B,
    3. Buhl M

    . Herpes simplex virus and Guillain-Barre polyradiculitis. BMJ 1975;1:192–93 doi:10.1136/bmj.1.5951.192 pmid:163112

    FREE Full Text
21. 21.↵
    2. Yuki N,
    3. Susuki K,
    4. Odaka M, et al

    . Overlapping Guillain-Barre syndrome and Bickerstaff's brainstem encephalitis associated with anti-GQ1b IgG antibody after herpes simplex virus infection. Acta Neurol Scand 2001;104:57–60 doi:10.1034/j.1600-0404.2001.00288.x pmid:11442445

    CrossRefPubMed
22. 22.↵
    2. Hunt DP,
    3. Muse VV,
    4. Pitman MB

    . Case records of the Massachusetts General Hospital: case 12-2013—an 18-year-old woman with pulmonary infiltrates and respiratory failure. N Engl J Med 2013;368:1537–45 doi:10.1056/NEJMcpc1209608 pmid:23594007

    CrossRefPubMed
23. 23.↵
    2. Willison HJ,
    3. Jacobs BC,
    4. van Doorn PA

    . Guillain-Barre syndrome. Lancet 2016;388:717–27 doi:10.1016/S0140-6736(16)00339-1

    CrossRefPubMed
24. 24.↵
    2. Grimaldi-Bensouda L,
    3. Alperovitch A,
    4. Besson G, et al

    ; Lucien Abenhaim for the GBS-PGRx Study Group. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol 2011;174:326–35 doi:10.1093/aje/kwr072 pmid:21652600

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Dardiotis E,
    3. Sokratous M,
    4. Tsouris Z, et al

    . Association between Helicobacter pylori infection and Guillain-Barre syndrome: a meta-analysis. Eur J Clin Invest 2020;50:e13218 doi:10.1111/eci.13218 pmid:32124432

    CrossRefPubMed
26. 26.↵
    2. Petras M,
    3. Lesna IK,
    4. Danova J, et al

    . Is an increased risk of developing Guillain-Barre syndrome associated with seasonal influenza vaccination? A systematic review and meta-analysis. Vaccines (Basel) 2020;8:E150 doi:10.3390/vaccines8020150 pmid:32230964

    CrossRefPubMed
27. 27.↵
    2. Rajabally YA,
    3. Uncini A

    . Outcome and its predictors in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 2012;83:711–18 doi:10.1136/jnnp-2011-301882 pmid:22566597

    Abstract/FREE Full Text
28. 28.↵
    2. Desforges M,
    3. Le Coupanec A,
    4. Brison E, et al

    . Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Adv Exp Med Biol 2014;807:75–96 doi:10.1007/978-81-322-1777-0_6 pmid:24619619

    CrossRefPubMed
29. 29.↵
    2. Kim JE,
    3. Heo JH,
    4. Kim HO, et al

    . Neurological complications during treatment of Middle East respiratory syndrome. J Clin Neurol 2017;13:227–33 doi:10.3988/jcn.2017.13.3.227 pmid:28748673

    CrossRefPubMed
30. 30.↵
    2. Sharma K,
    3. Tengsupakul S,
    4. Sanchez O, et al

    . Guillain-Barre syndrome with unilateral peripheral facial and bulbar palsy in a child: a case report. SAGE Open Med Case Rep 2019;7:2050313X19838750 doi:10.1177/2050313X19838750 pmid:30915222

    CrossRefPubMed